Regence Logos
Search: 
spacer
spacerspacer
Medical Policy

Laboratory Section

Policy Name Policy ID Number Date Modified
Allergy and Sensitivity Tests of Uncertain Efficacy LAB01 09/01/2023
Analysis of Proteomic and Metabolomic Patterns for Cancer Detection, Risk, Prognosis, or Treatment Selection LAB41 03/01/2024
Biochemical and Cellular Markers of Alzheimer's Disease LAB22 10/01/2023

New Policy Effective 05/01/2024:
Biomarker for Cardiovascular Disease

LAB78 02/01/2024
Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover LAB23 09/01/2023

Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor Cancers

LAB46 01/01/2024
COVID-19 Testing LAB74 11/21/2023

Drug Testing for Substance Use and Pain Management

LAB68 07/01/2023

New Policy Effective 06/01/2024:
Folate Testing

LAB79 03/01/2024
In Vitro Chemoresistance and Chemosensitivity Assays LAB06 01/01/2024

Invetigational Gene Expression, Biomarker, and Multianalyte Testing

LAB77 01/01/2024
Laboratory and Genetic Testing for Use of Fluoropyrimidine Chemotherapy (5-FU and Capecitabine) in Patients with Cancer LAB64 02/01/2024
Laboratory Tests for Organ Transplant Rejection LAB51 09/01/2023
Maternal Serum Analysis for Risk of Adverse Obstetric Outcomes LAB75 07/01/2023
Measurement of Lipoprotein-Associated Phospholipase A2 Lp-PLA2) in the Assessment of Cardiovascular Risk LAB63 07/01/2023

Measurement of Serum Antibodies to Selected Biologic Agents

LAB65 07/01/2023
Molecular Testing in the Management of Pulmonary Nodules LAB73

10/01/2023

Multi-biomarker Disease Activity Blood Test for Rheumatoid Arthritis LAB67 09/01/2023
Multianalyte and Gene Expression Assays for Predicting Recurrence in Colon Cancer LAB76 10/01/2023
Multianalyte Assays with Algorithmic Analyses for the Evaluation and Monitoring of Patients with Chronic Liver Disease LAB47 01/01/2024
Multimarker and Proteomics-based Serum Testing Related to Ovarian Cancer LAB60 03/01/2024
Placental Rapid Immunoassay for Detection of Fetal Membrane Rupture LAB57 02/01/2024
Protein Biomarkers and Multi-analyte Biomarker Tests for Screening, Detection, and/or Management of Prostate Cancer LAB69 02/01/2024
Salivary Hormone Testing for Aging and Menopause LAB36 03/01/2024
Serum Holotranscobalamin as a Marker of Vitamin B12 (i.e., Cobalamin) Status LAB44 04/01/2023
Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance LAB72 10/01/2023

Vitamin D Testing

LAB52 01/01/2024